JPRN-UMIN000007959
Completed
未知
Pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment - prevent a thin endometrium
Saiseikai Shimonoseki General Hospital0 sites61 target enrollmentMay 15, 2012
ConditionsInfertility
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Infertility
- Sponsor
- Saiseikai Shimonoseki General Hospital
- Enrollment
- 61
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients were excluded if they had myoma, adenomyosis, congenital uterine anomaly, or ovarian tumors. Patients were also excluded if they used estrogens, progesterone, androgens, or had chronic use of any medication, including nonsteroidial anti\-inflammatory agents.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Suspended
Not Applicable
A pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatmentA prospective Randomized Controlled Trial.JPRN-UMIN000007288Yamaguchi University Graduate School of Medicine61
Not yet recruiting
Not Applicable
Role of Endometrial Scratch in UnExplained infertility (RESCUE); A randomized clinical trialPACTR201604001405465Minia university postgraduate research office136
Completed
Not Applicable
Treating infertility caused by thin endometrium through the administration of Platelet-rich plasmaJPRN-UMIN000050227Haitham Abbassi private clinic15
Completed
Phase 2
Investigating the Prevention of Endometrial CAncer with Metformin (PECAM Study)Endometrial cancerBreast cancerCancer - Womb (Uterine or endometrial cancer)Cancer - BreastACTRN12614000838617Monash University130
Active, not recruiting
Not Applicable
A study to evaluate the effect on the endometrium of a new formulation containing 4 mg drospirenone (Drospirenone 4 mg film-coated tablet) administered over a period of 13 cycles. A monocentric, open, multiple dose trial in healthy female subjects at risk of pregnancyEUCTR2013-002300-13-BGCHEMO France